Brimonidine Tartrate Patents

Given below is the list of patents protecting Brimonidine Tartrate, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Brimonidine Tartrate's patents.

Latest Legal Activities on Brimonidine Tartrate's Patents

Given below is the list recent legal activities going on the following patents of Brimonidine Tartrate.

Activity	Date	Patent Number
Today's Critical Events
Payment of Maintenance Fee, 12th Year, Large Entity	22 Feb, 2019	US7265117
Patent Issue Date Used in PTA Calculation Critical	04 Sep, 2007	US7265117
Recordation of Patent Grant Mailed Critical	04 Sep, 2007	US7265117
Issue Notification Mailed Critical	15 Aug, 2007	US7265117
Dispatch to FDC	31 Jul, 2007	US7265117
Application Is Considered Ready for Issue Critical	13 Jul, 2007	US7265117
Issue Fee Payment Received Critical	09 Jul, 2007	US7265117
Issue Fee Payment Verified Critical	09 Jul, 2007	US7265117
Mail Notice of Allowance Critical	27 Jun, 2007	US7265117
Notice of Allowance Data Verification Completed Critical	23 Jun, 2007	US7265117

Brimonidine Tartrate's Family Patents

Full family tree